December 2024

How to diagnose the six most common grounds for pharmaceutical patent rejection — and the prosecution strategies that actually reverse […]

A deep-dive resource covering discovery frameworks, platform architectures, IP valuation, clinical case studies, ROI modeling, regulatory strategy, and the next

Part I: The Failing Commercial Architecture The commercial model that generated decades of reliable profit for large-cap pharmaceutical companies was